OTC Markets OTCPK - Delayed Quote USD

Reckitt Benckiser Group plc (RBGLY)

Compare
12.87 +0.79 (+6.54%)
At close: November 1 at 3:56 PM EDT
Loading Chart for RBGLY
DELL
  • Previous Close 12.08
  • Open 13.10
  • Bid 12.81 x 40000
  • Ask 12.92 x 40000
  • Day's Range 12.85 - 13.14
  • 52 Week Range 10.24 - 15.03
  • Volume 157,892
  • Avg. Volume 765,467
  • Market Cap (intraday) 44.411B
  • Beta (5Y Monthly) 0.09
  • PE Ratio (TTM) 22.98
  • EPS (TTM) 0.56
  • Earnings Date Oct 23, 2024
  • Forward Dividend & Yield 0.51 (3.92%)
  • Ex-Dividend Date Aug 5, 2024
  • 1y Target Est 13.97

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands. The company also offers home fragrances and devices; water softeners; home cleaning products; dish washes; toilet cleaners; disinfecting sprays wipes, laundry sanitisers, and others; sprays, baits, and plug-ins for pest control; stain removals; and fabric washing under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands. In addition, it provides nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. The company was founded in 1819 and is headquartered in Slough, the United Kingdom.

www.reckitt.com

40,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: RBGLY

View More

Related Videos: RBGLY

Performance Overview: RBGLY

Trailing total returns as of 11/1/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

RBGLY
1.84%
FTSE 100
5.74%

1-Year Return

RBGLY
1.18%
FTSE 100
11.68%

3-Year Return

RBGLY
11.93%
FTSE 100
12.98%

5-Year Return

RBGLY
4.35%
FTSE 100
12.81%

Compare To: RBGLY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RBGLY

View More

Valuation Measures

Annual
As of 11/1/2024
  • Market Cap

    44.45B

  • Enterprise Value

    54.65B

  • Trailing P/E

    22.91

  • Forward P/E

    15.04

  • PEG Ratio (5yr expected)

    1.15

  • Price/Sales (ttm)

    2.47

  • Price/Book (mrq)

    4.25

  • Enterprise Value/Revenue

    2.96

  • Enterprise Value/EBITDA

    13.74

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.78%

  • Return on Assets (ttm)

    7.51%

  • Return on Equity (ttm)

    17.91%

  • Revenue (ttm)

    14.33B

  • Net Income Avi to Common (ttm)

    1.54B

  • Diluted EPS (ttm)

    0.56

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    986M

  • Total Debt/Equity (mrq)

    112.52%

  • Levered Free Cash Flow (ttm)

    2.17B

Research Analysis: RBGLY

View More

Revenue vs. Earnings

Revenue 3.58B
Earnings 571M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

13.44
13.97 Average
12.87 Current
14.50 High
 

Company Insights: RBGLY

Research Reports: RBGLY

View More
  • Reckitt: Shares Rebound Strongly After Significant Win in Ongoing Premature Formula Litigation

    Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold the number-one or -two positions in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating around 35% of sales from emerging markets.

    Rating
    Price Target
     
  • Reckitt: Consensus Beat Sends Shares Higher Despite Anemic Hygiene Performance

    Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold the number-one or -two positions in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating around 35% of sales from emerging markets.

    Rating
    Price Target
     
  • Abbott and Reckitt: Latest Infant Formula Judgment Against Abbott Weighs on Shares

    Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold the number-one or -two positions in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating around 35% of sales from emerging markets.

    Rating
    Price Target
     
  • Abbott and Reckitt: Latest Infant Formula Judgment Against Abbott Weighs on Shares

    Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold the number-one or -two positions in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating around 35% of sales from emerging markets.

    Rating
    Price Target
     

People Also Watch